UBS AM’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.04M | Sell |
16,749
-366,058
| -96% | -$88.3M | ﹤0.01% | 1810 |
|
2025
Q1 | $93.2M | Sell |
382,807
-5,820
| -1% | -$1.42M | 0.02% | 558 |
|
2024
Q4 | $128M | Sell |
388,627
-52,471
| -12% | -$17.2M | 0.03% | 466 |
|
2024
Q3 | $148M | Buy |
441,098
+4,260
| +1% | +$1.43M | 0.04% | 418 |
|
2024
Q2 | $119M | Buy |
436,838
+14,681
| +3% | +$4.01M | 0.03% | 418 |
|
2024
Q1 | $146M | Sell |
422,157
-81,051
| -16% | -$28M | 0.05% | 348 |
|
2023
Q4 | $162M | Sell |
503,208
-71,322
| -12% | -$23M | 0.06% | 310 |
|
2023
Q3 | $206M | Buy |
574,530
+40,239
| +8% | +$14.4M | 0.09% | 228 |
|
2023
Q2 | $256M | Hold |
534,291
| – | – | 0.12% | 175 |
|
2023
Q1 | $256M | Buy |
534,291
+114,866
| +27% | +$55M | 0.12% | 175 |
|
2022
Q4 | $176M | Buy |
419,425
+25,392
| +6% | +$10.7M | 0.09% | 245 |
|
2022
Q3 | $164M | Buy |
394,033
+19,245
| +5% | +$8.03M | 0.09% | 240 |
|
2022
Q2 | $186M | Buy |
374,788
+28,416
| +8% | +$14.1M | 0.1% | 224 |
|
2022
Q1 | $195M | Buy |
346,372
+2,495
| +0.7% | +$1.41M | 0.08% | 259 |
|
2021
Q4 | $260M | Sell |
343,877
-13,723
| -4% | -$10.4M | 0.1% | 217 |
|
2021
Q3 | $267M | Sell |
357,600
-12,576
| -3% | -$9.38M | 0.11% | 191 |
|
2021
Q2 | $239M | Sell |
370,176
-12,624
| -3% | -$8.13M | 0.1% | 214 |
|
2021
Q1 | $219M | Sell |
382,800
-120,757
| -24% | -$69M | 0.1% | 223 |
|
2020
Q4 | $294M | Buy |
503,557
+117,413
| +30% | +$68.4M | 0.14% | 146 |
|
2020
Q3 | $199M | Sell |
386,144
-26,428
| -6% | -$13.6M | 0.11% | 176 |
|
2020
Q2 | $186M | Buy |
412,572
+46,288
| +13% | +$20.9M | 0.11% | 177 |
|
2020
Q1 | $128M | Sell |
366,284
-75,058
| -17% | -$26.3M | 0.09% | 220 |
|
2019
Q4 | $163M | Buy |
441,342
+22,837
| +5% | +$8.45M | 0.1% | 219 |
|
2019
Q3 | $139M | Buy |
418,505
+21,281
| +5% | +$7.08M | 0.09% | 228 |
|
2019
Q2 | $124M | Buy |
397,224
+10,536
| +3% | +$3.29M | 0.09% | 249 |
|
2019
Q1 | $118M | Sell |
386,688
-28,125
| -7% | -$8.6M | 0.09% | 249 |
|
2018
Q4 | $96.3M | Buy |
414,813
+160,075
| +63% | +$37.2M | 0.08% | 263 |
|
2018
Q3 | $79.7M | Sell |
254,738
-19,441
| -7% | -$6.08M | 0.06% | 335 |
|
2018
Q2 | $79.1M | Sell |
274,179
-6,296
| -2% | -$1.82M | 0.06% | 350 |
|
2018
Q1 | $70.1M | Sell |
280,475
-78,936
| -22% | -$19.7M | 0.06% | 372 |
|
2017
Q4 | $85.8M | Sell |
359,411
-51,887
| -13% | -$12.4M | 0.07% | 300 |
|
2017
Q3 | $91.4M | Sell |
411,298
-15,829
| -4% | -$3.52M | 0.08% | 266 |
|
2017
Q2 | $96.7M | Sell |
427,127
-9,706
| -2% | -$2.2M | 0.09% | 252 |
|
2017
Q1 | $87.1M | Sell |
436,833
-29,952
| -6% | -$5.97M | 0.09% | 254 |
|
2016
Q4 | $85.1M | Buy |
466,785
+38,714
| +9% | +$7.06M | 0.1% | 232 |
|
2016
Q3 | $70.1M | Sell |
428,071
-20,763
| -5% | -$3.4M | 0.08% | 281 |
|
2016
Q2 | $64.2M | Buy |
448,834
+33,077
| +8% | +$4.73M | 0.07% | 294 |
|
2016
Q1 | $56.8M | Sell |
415,757
-55,093
| -12% | -$7.53M | 0.07% | 322 |
|
2015
Q4 | $65.3M | Sell |
470,850
-105,749
| -18% | -$14.7M | 0.07% | 286 |
|
2015
Q3 | $77.4M | Sell |
576,599
-13,322
| -2% | -$1.79M | 0.09% | 266 |
|
2015
Q2 | $88.8M | Buy |
589,921
+36,118
| +7% | +$5.44M | 0.09% | 254 |
|
2015
Q1 | $74.9M | Sell |
553,803
-8,636
| -2% | -$1.17M | 0.07% | 295 |
|
2014
Q4 | $67.8M | Sell |
562,439
-6,156
| -1% | -$742K | 0.06% | 320 |
|
2014
Q3 | $64.5M | Sell |
568,595
-17,180
| -3% | -$1.95M | 0.06% | 324 |
|
2014
Q2 | $70.1M | Sell |
585,775
-12,096
| -2% | -$1.45M | 0.07% | 301 |
|
2014
Q1 | $76.6M | Sell |
597,871
-36,526
| -6% | -$4.68M | 0.08% | 274 |
|
2013
Q4 | $78.4M | Buy |
634,397
+69,735
| +12% | +$8.62M | 0.09% | 249 |
|
2013
Q3 | $66.4M | Sell |
564,662
-27,200
| -5% | -$3.2M | 0.08% | 272 |
|
2013
Q2 | $66.4M | Buy |
+591,862
| New | +$66.4M | 0.09% | 258 |
|